Inspire Veterinary Partners, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
Erinn Thomas-Mackey has resigned from the Board of Directors of Inspire Veterinary Partners Inc., effective February 26, 2026.
Inspire Veterinary Partners, Inc. announced its Class A common stock was delisted from Nasdaq and began trading on the OTCQB Venture Market under the symbol IVPR.
Inspire Veterinary Partners, Inc. converted $25,000 of debt into 2.5 million shares of Class A common stock with Target Capital 1 LLC.
Inspire Veterinary Partners, Inc. has increased its authorized Class A common stock from 100 million to 700 million shares, effective January 9, 2026.
Inspire Veterinary Partners, Inc. has entered into a securities purchase agreement for a $975,000 secured convertible promissory note and issued 2 million commitment shares, with proceeds for working capital and acquisitions.
Inspire Veterinary Partners, Inc. converted $150,000 of outstanding debt into 3,000,000 shares of common stock with Target Capital 1 LLC.
Inspire Veterinary Partners, Inc. has entered into a consulting agreement with 622 Capital LLC for business development services, compensating them with 9.45 million shares of Class A common stock.
Inspire Veterinary Partners, Inc. stockholders re-elected all seven directors and ratified M&K CPAS, PLLC as the independent registered public accounting firm for fiscal year 2025 at the Annual Meeting.
Inspire Veterinary Partners, Inc. has amended promissory notes and Series B Preferred Stock terms, significantly lowering conversion floor prices and allowing a partial preferred stock redemption.
Inspire Veterinary Partners, Inc. received a Nasdaq delisting notice due to minimum bid price non-compliance but has appealed the decision, staying immediate suspension.
Inspire Veterinary Partners, Inc. received a Nasdaq notice for non-compliance with minimum bid price, facing delisting without an appeal.
Inspire Veterinary Partners, Inc. has issued $357,142.86 in Senior Convertible Promissory Notes to two investors, raising $250,000 for general working capital.
Inspire Veterinary Partners, Inc. has dismissed Kreit & Chiu CPA LLP and appointed M&K CPAS, PLLC as its new independent registered public accounting firm, effective October 16, 2025.
Inspire Veterinary Partners, Inc. completed an additional closing in a private placement, raising approximately $1.0 million through the sale of Series B convertible preferred stock and warrants to new institutional investors.
Inspire Veterinary Partners, Inc. announced it has regained compliance with Nasdaq's minimum stockholders' equity requirement, resolving a previous listing deficiency.
Inspire Veterinary Partners regains compliance with Nasdaq's minimum stockholders' equity requirement following a $5 million private placement.
Inspire Veterinary Partners, Inc. has secured up to $60 million in new financing through a combination of convertible preferred stock, warrants, and a common stock purchase agreement to bolster working capital and fund acquisitions.
8-K: Inspire Veterinary Partners Expands Florida Presence with Strategic Debary Animal Clinic Acquisition
Inspire Veterinary Partners, Inc. has successfully acquired Debary Animal Clinic and its associated real estate for a total of $2.057 million, projecting an additional $1.8 million in annualized revenue and expanding its national network to 14 animal hospitals.
Inspire Veterinary Partners, Inc. has entered into two securities purchase agreements to raise a net $258,000 through high-interest, short-term original issue discount notes, which include significant default penalties and highly dilutive conversion features for the lenders.
Inspire Veterinary Partners names current CEO Kimball Carr as Chairman of the Board, effective May 1, 2025.
Inspire Veterinary Partners names Lynley Kees Chief People Officer and reports a 500% increase in veterinary hiring year-to-date compared to 2024.
Inspire Veterinary Partners, Inc. has entered into a two-year employment agreement with its current CEO, Kimball Carr, outlining his compensation, duties, and termination conditions.
8-K: Inspire Veterinary Partners Faces Nasdaq Delisting Threat Due to Stockholders' Equity Deficiency
Inspire Veterinary Partners, Inc. received a notice from Nasdaq regarding non-compliance with minimum stockholders' equity requirements, potentially leading to delisting.
8-K: Inspire Veterinary Partners Announces $2 Million Registered Direct Offering Priced At-The-Market
Inspire Veterinary Partners has entered into a securities purchase agreement for a registered direct offering, expecting to raise $2 million initially and potentially up to $4 million more upon warrant exercises.
Inspire Veterinary Partners, Inc. has entered into a two-year employment agreement with Richard Frank, appointing him as the Chief Financial Officer (CFO) with a base salary of $255,000 and potential performance-based bonuses and stock awards.
Inspire Veterinary Partners increased its authorized Class A common stock to 100 million shares and has regained compliance with Nasdaq's minimum bid price requirement.
Inspire Veterinary Partners will implement a 1-for-25 reverse stock split effective January 27, 2025, to comply with Nasdaq's minimum bid price requirement.
Inspire Veterinary Partners extends Chief Financial Officer Richard Frank's employment agreement to March 1, 2025, maintaining all existing terms.
Inspire Veterinary Partners has implemented a 1-for-25 reverse stock split to increase its share price and regain compliance with Nasdaq listing requirements.
Inspire Veterinary Partners has entered into an agreement to sell up to $25 million of its common stock through an at-the-market offering.